Jordan Curnes is a highly accomplished individual in the field of medical technology and business. With an impressive background in economics and finance from the University of Notre Dame, and an MBA from Duke University's Fuqua School of Business, he possesses a strong foundation of knowledge and expertise.

Mr. Curnes co-founded MicroTransponder, a pioneering company that focuses on developing innovative therapies based on Paired Vagus Nerve Stimulation (VNS). This groundbreaking therapy has proven to be effective in treating various neurological conditions, including stroke rehabilitation and tinnitus.

His tenure as President and COO at MicroTransponder exemplified his exceptional leadership abilities and strategic mindset. Under his guidance, the company thrived and made significant advancements in the field of medical technology.

In addition to his contributions at MicroTransponder, Jordan Curnes has been actively involved in the entrepreneurial community as a Co-Founder and Board Member of IrishAngels. This organization provides support and investment opportunities for startups, fostering innovation and development.

With his diverse background and profound knowledge of the medical technology sector, Jordan Curnes is a respected figure in the industry. His dedication to improving patient outcomes and his business acumen make him a valuable asset to any organization he is a part of.